– vu les initiatives suivantes: European and Developing Countries Clinical Trials Partnersh
ip (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Develop
ment (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), GAVI (Global Alliance for Vaccines and Immunization)/The Vaccine Fund, Medicines for Malaria Ventures (MMV), Roll Back Malaria (RBM) Partnership, Drugs for Neglected Dise
...[+++]ases Initiative (DNDi), et autres associations qui œuvrent dans le domaine de la recherche et du développement de médicaments destinés à lutter contre les maladies négligées,- having regard to the European and Developing Countries Clinical Trials Partnersh
ip (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Develop
ment (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), GAVI (Global Alliance for Vaccines and Immunization)/The Vaccine Fund, Medicines for Malaria Venture (MMV), Roll Back Malaria (RBM) Partnership and the Drugs for Neglected Disease
...[+++]s Initiative (DNDi) and others who are working to research and develop drugs for neglected diseases,